Your session is about to expire
← Back to Search
Colonoscopy vs Stool Testing for Colorectal Polyps (COOP Trial)
N/A
Recruiting
Led By Audrey H Calderwood, MD, MS
Research Sponsored by Dartmouth-Hitchcock Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1 year after surveillance colonoscopy, annually after each completed fit for up to 6 years
Awards & highlights
No Placebo-Only Group
Summary
This trial compares two ways to monitor colon health after polyps are removed: FIT testing & colonoscopy. People aged 70-82 with a history of polyps can take part.
Who is the study for?
Adults aged 70-82 with a history of one or two non-advanced colorectal polyps and due for surveillance colonoscopy can join. They must speak English or Spanish and be able to consent. Those with serious heart, lung, liver, kidney diseases, dementia affecting daily activities, recent stroke or cancer diagnosis are excluded.
What is being tested?
The trial is comparing yearly stool tests (FIT) versus the standard colonoscopy to monitor older adults who previously had colon polyps. It's a randomized controlled trial across multiple sites where participants are randomly assigned to either method.
What are the potential side effects?
Colonoscopy may cause discomfort, bleeding, or perforation of the colon wall in rare cases. Stool testing (FIT) is generally safe but may lead to follow-up procedures like a colonoscopy if results indicate abnormal findings.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 1 year after surveillance colonoscopy, annually after each completed fit for up to 6 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 year after surveillance colonoscopy, annually after each completed fit for up to 6 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Advance Directives
Secondary study objectives
Change from baseline Emotional benefit of surveillance assessed by a modified version of the Psychological Consequences Questionnaire (PCQ)
Colorectal Carcinoma
Change from baseline Satisfaction and Trust of colorectal screening testing assessed by Tiro et al (2005) Response Efficacy sub-scale from the general colorectal cancer screening survey.
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: FITActive Control1 Intervention
FIT (annual)
Group II: ColonoscopyActive Control1 Intervention
Surveillance colonoscopy (one time)
Find a Location
Who is running the clinical trial?
Dartmouth-Hitchcock Medical CenterLead Sponsor
537 Previous Clinical Trials
2,530,770 Total Patients Enrolled
Patient-Centered Outcomes Research InstituteOTHER
574 Previous Clinical Trials
27,070,013 Total Patients Enrolled
Audrey H Calderwood, MD, MSPrincipal InvestigatorDartmouth-Hitchcock Medical Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a history of inflammatory bowel disease.I speak English or Spanish.I have had colorectal cancer in the past.I have had colorectal polyps in the past.I am unable to sign a consent form.I have a genetic condition like Lynch Syndrome that increases my risk for colorectal cancer.I have serious health issues that make cancer screening unsuitable for me.
Research Study Groups:
This trial has the following groups:- Group 1: FIT
- Group 2: Colonoscopy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger